Biotechnology

Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family

Associates of Cape Cod is a biotechnology firm that offers endotoxin detection reagents and contract testing services.

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues.

Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genet

Frontier Science renders a wide range of research services with clinical trials to pharmaceutical companies and other organizations.

6K develops materials into products that will advance industries in manufacturing, renewable energy, aerospace, and consumer electronics.

Isotopen Technologien München is a privately held biotechnology and radiopharmaceutical group of companies.

Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer c

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understandi

Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.

SCHOTT MINIFAB is ISO 9001 & ISO 13485 certified, offering contract design, development and manufacturing of microfluidic consumables and high-density microarrays for diagnostic and life science research. Enabling product developers to get their innovation to market faster and more efficiently. We

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy to treat solid tumors.

Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In

Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services.

INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and brand

Invivyd is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies.

Vizgen is the life sciences company developing the next generation of Spatially Resolved Transcriptomics.

Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.

CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies.

Neomorph is a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets’.

Allakos is developing therapeutic antibodies that that selectively target eosinophils and mast cells, cells that play a significant role in many diseases

Procures, processes, and distributes cryopreserved human amniotic membrane for transplantation, research, and ocular, wound, and foot reconstruction uses.

Precision BioSciences utilizes its proprietary ARCUS Genome Editing method to overcome cancers, cure genetic diseases, and enable development of safer food.

Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Bioscience

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on

Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR).

Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manu

We are revolutionizing the treatment for severe allergic reactions with the development of an easy-to-use, needle-free epinephrine nasal spray.

Zageno's mission is to accelerate scientific innovation by streamlining biotech purchasing processes with its award-winning, first-of-its-kind e-commerce platform.

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.

ATUM is a technology platform that combines the design of experiments with machine learning tools, allowing them to optimize their biological systems for their properties. The GPS technology provides an integrated bioengineering suite of solutions

Werewolf Therapeutics is an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.

Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. Fro

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Spectrix Analytical Services provides scientific support services, quality control, and troubleshooting in R&D and production environments.

Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences.

Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.

Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's resear

Stelis Biosource is a leading, fully integrated biopharmaceutical contract development and manufacturing organization.

Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies that provide physicians and patients with improved results. AcQMap, AcQRef and AcQGuide devices are CE Marked and FDA cleared. Please review the Instructions for Use for a complete listing of

Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-On

Paradromics is bringing to market the first high data rate interface between brains and computers to create a new industry where medical challenges are met with technical solutions